Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore Opdivo (nivolumab), an immunotherapy that empowers your immune system to fight cancer. Learn about its uses for lung, skin, kidney, and other cancers, how it works, side effects, and more.
Facing a cancer diagnosis can feel like navigating a storm. You're probably looking for information, for hope, and for treatments that can make a real difference. Today, we're going to talk about Opdivo, also known by its generic name, nivolumab. It's a type of treatment called immunotherapy, and it's changing the way we fight certain cancers. Think of it as a way to wake up your own body's defenses to attack the disease.
Opdivo isn't just another chemotherapy drug. It belongs to a special class called immune checkpoint inhibitors. These drugs work by targeting specific proteins, like PD-1 (programmed death receptor-1), which cancer cells sometimes use to hide from your immune system. By blocking these 'checkpoints,' Opdivo helps your immune cells, particularly T-cells, recognize and destroy cancer cells more effectively. It's a sophisticated approach, harnessing your body's natural power.
This medication is a biologic, meaning it's derived from living organisms, and it's administered as an intravenous (IV) infusion – essentially, an injection into your vein given over a period of time. It's a prescription medication, so it's always used under the guidance of a healthcare professional.
Opdivo has shown effectiveness in treating a range of cancers, both in adults and, in some cases, in children. It's important to remember that its use often depends on the specific type of cancer, its stage, and whether it has spread. It can be used alone or in combination with other medications, like Yervoy (ipilimumab), to enhance its effectiveness.
The decision to use Opdivo, and in what combination, is a complex one, made by your oncologist after careful consideration of your individual medical profile.
We've touched on this, but let's expand. Opdivo, or nivolumab, is an immunotherapy. Its primary mechanism is to block the PD-1 protein receptor found on T-cells. Normally, PD-1 acts as a 'brake' on the immune system, preventing T-cells from attacking healthy cells. However, some cancer cells produce a protein called PD-L1, which binds to PD-1 on T-cells. This binding signals the T-cells to stand down, allowing the cancer to evade immune detection. Opdivo steps in by binding to the PD-1 receptor on the T-cells, effectively preventing PD-L1 from attaching. This 'releases the brake,' allowing your T-cells to recognize and attack the cancer cells.
It's like removing a camouflage cloak from the cancer cells, making them visible again to your body's security forces – your immune system.
Opdivo is not a pill you take at home. It's given as an IV infusion, meaning a healthcare professional administers it directly into your vein. The duration of the infusion is typically around 30 minutes, though this can vary.
The dosage and how often you receive it are highly personalized. Factors influencing this include:
Your doctor will determine the optimal schedule, which could be once every 2, 3, 4, or 6 weeks for adults. For children, the frequency might be once every 2, 3, or 4 weeks, based on their treatment plan.
Like any powerful medication, Opdivo can have side effects. While many people tolerate it well, it's essential to be aware of the possibilities, both mild and serious. Your healthcare team will monitor you closely, but knowing what to look out for empowers you to communicate effectively.
These are often manageable with supportive care. However, Opdivo can also cause more serious immune-related side effects. This happens when the activated immune system mistakenly attacks healthy tissues and organs.
It is vital to contact your doctor immediately if you experience any new or worsening symptoms, especially those listed above. If you believe you are experiencing a medical emergency, call 911 or your local emergency services right away.
One piece of good news is that Opdivo does not have known interactions with other medications, herbs, supplements, or foods. This simplifies treatment management. However, medical knowledge is always evolving, and it's still wise to keep your doctor informed about everything you are taking.
Your oncologist and their team are your primary resource. You should consult them:
Never hesitate to reach out to your healthcare provider. They are there to support you through every step of your treatment journey.
Opdivo is a treatment, not a preventative measure for cancer. However, managing its side effects is a form of 'prevention' against them becoming severe. This involves:
Opdivo can lead to long-term remission and is considered a highly effective treatment for many types of cancer. While 'cure' is a strong word in cancer treatment, Opdivo aims to significantly control or eliminate the cancer, offering patients a better quality of life and longer survival.
No, Opdivo is an immunotherapy drug. It works differently from traditional chemotherapy, which targets rapidly dividing cells (both cancerous and healthy). Opdivo leverages your immune system to fight cancer.
Opdivo is not known to directly cause Type 1 Diabetes. However, as an immunotherapy, it can sometimes trigger autoimmune conditions where the immune system attacks healthy organs. In rare cases, this could potentially affect the pancreas, which produces insulin. If you have concerns about diabetes or autoimmune conditions, discuss them with your doctor.
Opdivo (nivolumab) is an anti-PD-1 antibody, while Yervoy (ipilimumab) is an anti-CTLA-4 antibody. Both are immunotherapies, but they work on different targets within the immune system. They are often used in combination because they can provide a synergistic effect, boosting the immune response against cancer more effectively than either drug alone.
Opdivo is a biologic drug and is not currently available in a generic form. Biosimilar versions may emerge in the future, similar to how generic drugs are developed for non-biologic medications.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026
Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026